Xianjun Huang Selected Research

Encephalomalacia

1/2022

Pre-Existing Non-Disabling Encephalomalacia Confers Risk to Stroke Outcomes After Endovascular Treatment.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Xianjun Huang Research Topics

Disease

10	Ischemic Stroke 01/2022 - 01/2012
9	Stroke (Strokes) 01/2022 - 01/2015
4	Brain Edema (Cerebral Edema) 01/2022 - 10/2019
2	Cerebral Infarction 01/2022 - 01/2020
1	Rupture 02/2022
1	Encephalomalacia 01/2022
1	Intracranial Hemorrhages (Intracranial Hemorrhage) 02/2021
1	Hypertension (High Blood Pressure) 01/2021
1	Atrial Fibrillation 01/2021
1	Moyamoya Disease (Moya-Moya Disease) 09/2013

Drug/Important Bio-Agent (IBA)

3	Indicators and Reagents (Reagents)IBA 01/2022 - 01/2012
2	Blood Glucose (Blood Sugar)IBA 01/2022 - 01/2020
1	Tissue Plasminogen Activator (Alteplase)FDA Link 01/2021
1	Glucose (Dextrose)FDA LinkGeneric 01/2021
1	Cysteine (L-Cysteine)FDA Link 05/2019
1	Chemokine ReceptorsIBA 05/2019
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2015
1	Brain-Derived Neurotrophic Factor (BDNF)IBA 01/2015
1	Tissue Inhibitor of Metalloproteinase-2IBA 09/2013
1	Platelet-Derived Growth Factor beta Receptor (Receptor, Platelet Derived Growth Factor beta)IBA 09/2013

Therapy/Procedure

9	Thrombectomy 01/2022 - 01/2019
2	Stents 01/2022 - 01/2019
2	Therapeutics 01/2022 - 01/2021
1	Sutures (Suture) 02/2022
1	Punctures 01/2020